IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023 08:00 ET
|
Imunon, Inc.
Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT...
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023 06:50 ET
|
Synlogic, Inc.
- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – - Recent milestones include receipt of Rare Pediatric and Orphan Drug Designations from the FDA, and...
IMUNON to Hold First Quarter 2023 Financial Results and Business Update Conference Call on Thursday, May 11, 2023
May 04, 2023 08:30 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
GeoJunxion NV (ticker: GOJXN.AS) - Financiële en Operationele update 3de kwartaal (januari '23 - maart '23) en eerste 9 maanden van boekjaar 2022-23 (juli '22 - maart '23)
May 04, 2023 02:00 ET
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Financiële en Operationele update 3de kwartaal (januari '23 - maart '23) en eerste 9 maanden van boekjaar 2022-23 (juli '22 - maart '23) Belangrijkste punten: ...
GeoJunxion NV (ticker: GOJXN.AS) - Financial & Business update Q3 (January ‘23 - March ‘23) and first 9 months of F.Y. 2022-23 (July ‘22 - March ‘23)
May 04, 2023 02:00 ET
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Financial & Business update Q3 (January ‘23 - March ‘23) and first 9 months of F.Y. 2022-23 (July ‘22 - March ‘23) Key Facts: 60% revenue growth for the...
Nexstim Oyj:n liike- ja kliinisen toiminnan päivitys, tammi-maaliskuu 2023
May 03, 2023 02:00 ET
|
Nexstim Oyj
Lehdistötiedote, Helsinki, 3.5.2023 klo 9.00 (EEST) Nexstim Oyj:n liike- ja kliinisen toiminnan päivitys, tammi-maaliskuu 2023 Nexstim Oyj (NXTMH:HEX) (jäljempänä ”Nexstim” tai ”Yhtiö”) kertoo...
Nexstim Plc Business and Clinical Update Q1 2023
May 03, 2023 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 3 May 2023 at 9 AM (EEST) Nexstim Plc Business and Clinical Update Q1 2023 Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) announces the key highlights of the Company’s...
Eightco Holdings Inc. Reports Full Year 2022 Financial Results and Provides Business Update
April 17, 2023 19:10 ET
|
Eightco Holdings Inc.
SAFETY HARBOR, Florida, April 17, 2023 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) today provided a corporate update in conjunction with the filing of its Annual Report, on Form 10-K...
Wejo Announces Fourth Quarter and Full-Year 2022 Results
April 03, 2023 08:04 ET
|
Wejo Limited
MANCHESTER, United Kingdom, April 03, 2023 (GLOBE NEWSWIRE) -- Wejo Group Limited (NASDAQ: WEJO) (“Wejo” or the “Company”), a global leader in cloud and software analytics for connected, electric,...
SeaStar Medical Reports 2022 Financial Results and Provides a Business Update
March 30, 2023 19:23 ET
|
SeaStar Medical Holding Corporation
DENVER, March 30, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...